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EDITORIAL
Mesangial cells defy LDL receptor paradigm
Ever since it was recognized that the cellular interac- uptake of native LDL. Hence, even at normolipidemic
tions in atherogenesis may fundamentally be no different conditions, inflammation could lead to lipid-mediated
from those in other chronic fibroproliferative diseases like glomerular injury. Before this novel pathway will be
glomerulosclerosis, investigators have studied whether generally accepted, it will be important to investigate to
novel concepts and mechanisms that were reported to what extent monokine-induced LDL receptor dysfunc-
contribute to the pathogenesis of the atherosclerotic ar- tion contributes to the uptake of cholesterol by mesangial
teries would also lead to “glomerular atherosclerosis” cells in vivo. During inflammation, not only monokines
[1–3]. For example, glomeruli can become infiltrated by are produced, but oxygen-reactive species are also gener-
monocytes that, upon ingestion of excessive amounts of ated that may avidly modify lipoproteins and convert
cholesterol esters, transform into foam cells. The con- them into bait for the scavenger receptors [6]. As in vitro
tractile glomerular mesangial cells can subsequently pro- cultured mesangial cells highly prefer oxidized LDL over
liferate in a way comparable to vascular smooth muscle native LDL [7], one might even wonder whether suffi-
cells and an excessive buildup of extracellular matrix cient amounts of native LDL will be present in the in-
takes place within the inflamed mesangium similar to flamed glomerulus to contribute to foam cell formation.
atheromatous arteries. On the other hand, unlike lipoproteins trapped into the
Interestingly, in a study published in this month’s issue arterial wall, facing an environment that may facilitate
of Kidney International, a novel, potentially pathogenic, oxidative modification, lipoproteins that enter the mes-
mechanism in glomerulosclerosis is reported that, in its angium remain in a plasma environment and would thus
turn, may well contribute to our understanding of athero- be expected to be protected from oxidative modification
genesis. Knowing that inflammation is an aggrevating fac- by circulating antioxidants and high-density lipoprotein
tor in atherogenesis, Ruan et al investigated the effect of (HDL).
monokines on the in vitro uptake of native low-density Nevertheless, the concept of LDL receptor dysregula-
lipoprotein (LDL) by a human mesangial cell line (HMCL) tion is highly interesting and, as usually happens when
[4]. As expected, it appeared impossible to convert the one encounters an innovative dogma-defying mecha-
mesangial cell to foam cells by adding native LDL. In line nism, it immediately triggers follow-up hypotheses. For
with the classical LDL receptor paradigm, LDL receptor instance, as brought forward by the authors, it might
activity in the resting mesangial cells obeys a tight feed- help to explain the observed abnormal glomerular depo-
back control that serves to maintain constant membrane sition of LDL inflammatory renal diseases [8].
cholesterol levels [5]. Surprisingly, in the presence of either Obviously, if LDL receptor dysregulation could also
tumor necrosis factor- (TNF-) or interleukin-1 (IL-1), be demonstrated for vascular smooth muscle cells, this
the addition of native LDL to the mesangial cells readily novel pathway could link systemic infection to the devel-
caused foam cell formation. The authors demonstrated opment of atherosclerosis that can be demonstrated in,
that the normal down-regulation of the LDL receptor, again, normo-cholesterolemic animals [9]. Almost 20
mediated by the inhibition of the proteolytic release of years ago Dr. Moorhead was the first to introduce the
a membrane-bound LDL receptor transcription factor, concept that the pathogenesis of atherosclerosis and glo-
the sterol regulatory element-binding protein (SREBP), merulosclerosis could be highly similar. Who knows, to-
is overridden in the presence of the inflammatory cyto- day, he and his research associates again are the first to
kines. The authors proposed an interesting novel path- teach the atherosclerosis research community a “lesson
way, speculating that during inflammatory glomerular from the kidney.”
disease, monokine-induced LDL receptor dysregulation
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